Prognostic Role of P27kip1 and Epidermal Growth Factor Receptor in Transitional Cell Carcinoma of the Bladder

Author： Valentine Andrea   Ritchie Joan L.   Nevin Gerald B.   McKeown Stephanie R.  

Publisher： Ashgate Publishing Ltd

ISSN： 1561-0950

Source： UroOncology, Vol.2, Iss.1, 2002-01, pp. : 41-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal growth factor receptor – targeted molecular therapeutics for head and neck squamous cell carcinoma

By Egloff Ann Marie   Grandis Jennifer  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 639-647

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic and Preventive Effects of an Epidermal Growth Factor Receptor Inhibitor on Oral Squamous Cell Carcinoma

By Ge H   Liu H   Fu Z   Sun Z  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 455-466

Field House Publishing

Access to resources Recommend Favorite

Treatment of Squamous Cell Carcinoma of the Head and Neck in the Metastatic and Refractory Settings: Advances in Chemotherapy and the Emergence of Small Molecule Epidermal Growth Factor Receptor Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 666-673

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

By Dancey Janet E.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1125-1138

Adis International

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite